Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.Ruben Bill, Matteo Montani, Benedikt Blum, Jean-François Dufour, Robert Escher, Michael Bühlmann
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app